Repairing Broken Hearts; Stem Cells and Medicine  

Oleh:

[s.n]

Jenis: Article from Bulletin/Magazine
Dalam koleksi: The Economist (http://search.proquest.com/) vol. 401 no. 8760 (Nov. 2011), page 77.
Topik: Paralysis; Research & Development--R&D Stem Cells; Gene therapy; Biotechnology Industry; Medical Research; Spinal Cord Injuries; Medical Technology; Cardiovascular Disease
Fulltext: Stem Cells and Medicine.pdf (44.5KB)

Ketersediaan

Perpustakaan Pusat (Semanggi) Nomor Panggil: EE29.69 Non-tandon: 1 (dapat dipinjam: 0) Tandon: tidak ada

Lihat Detail Induk

Isi artikel

It has been a mixed week for proponents of regenerative medicine. The bad news for those who have hopes of the field is that Geron, an American firm that was a pioneer of the therapeutic use of stem cells, is pulling out of the business. It is ending (or selling, if it can find a buyer) a project that was testing embryonic stem cells as a treatment for people paralysed by injuries to their spinal cords. The reason, it said, is financial. At a time when it is hard to raise new capital, the firm has decided to concentrate on anticancer therapies that, it hopes, are nearer to being commercial propositions than the stem-cell study is. The good news for the field of stem-cell therapy comes from a paper published in this week's Lancet by Roberto Bolli of the University of Louisville and his colleagues. They have used more specialised stem cells - ones that spin off only cardiac cells - to repair the hearts of people with heart failure. If their method can be made routine, it will bring enormous benefits

Opini Anda

Klik untuk menuliskan opini Anda tentang koleksi ini!

Kembali